<DOC>
	<DOCNO>NCT02155803</DOCNO>
	<brief_summary>ACTHAR Gel activity sarcoidosis associate hypercalciuria calcium dysregulation .</brief_summary>
	<brief_title>ACTHAR GEL Sarcoidosis-Associated Calcium Dysregulation : An Open-label Pilot Study</brief_title>
	<detailed_description>Sarcoidosis multisystem granulomatous disease unknown cause . Although sarcoidosis commonly affect lung , may affect organ . Although corticosteroid recognize drug choice sarcoidosis . ACTH ( adrenocorticotropic hormone ) drug FDA-approved disorder . However , limited data efficacy ACTH condition . Calcium metabolism disregulated active sarcoidosis . The primary abnormality calcium metabolism stem increase 1-Î± hydroxylase activity sarcoid alveolar macrophage convert 25-hydroxyvitamin D 1 , 25-dihydroxyvitamin D , active form vitamin . This result hypercalcemia , hypercalciuria , nephrocalcinosis , nephrolithiasis , interstitial nephritis , glomerulonephritis , acute chronic kidney disease . Importantly , almost renal manifestation stem disordered calcium metabolism . Unlike organ manifestation sarcoidosis , disorder calcium metabolism common white compare african americans.Compared hypercalcemia , hypercalciuria three time common sarcoidosis , nevertheless , largely ignore . In general , patient hypercalcemia advise avoid sunlight , curtail intake major source dietary calcium vitamin D , drink ample fluids.If patient symptomatic , serum calcium great 11 mg/dl , serum creatinine elevate , patient nephrolithiasis , drug therapy usually require . The drug choice prednisone initial daily dose 20 - 40 mg/day.Unfortunately , prolong corticosteroid therapy may result unacceptable side effect include osteoporosis . This particularly important elevate calcitriol observed patient sarcoidosis jeopardize bone structure resorption . Alternative medication show benefit sarcoidosis associate calcium dysregulation include chloroquine , hydroxychloroquine , ketoconazole . Not may ACTHER GEL obvious anti-inflammatory effect result corticosteroid production , may also activate melanocortin receptor . The melanocortin system powerful anti-inflammatory property may beneficial treatment sarcoidosis . We believe several specific advantage assess effectiveness anti-sarcoidosis therapy examine sarcoidosis-associated disorder calcium metabolism . 1 . The measure granulomatous activity ( serum calcium , urinary calcium , serum 25-hydroxyvitamin D , serum 1 , 25-dihydroxyvitamin D level ) directly relate granulomatous inflammation sarcoidosis . 2 . These parameter accurately objectively quantify . This important issue sarcoidosis endpoint involvement lung , skin , eye problematic either inexact and/or unidimensional . 3 . These constituent easily use clinically monitor sarcoidosis . This case form sarcoidosis include involvement lung skin . - Although hypercalciuria disorder calcium metabolism common manifestation sarcoidosis lung involvement , little evidence anti-granulomatous response disease organ specific . In randomized double-blind placebo control trial infliximab pulmonary sarcoidosis , extrapulmonary sarcoidosis also respond therapy .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>1 . Age great 18 year old . 2 . Able understand English point comprehend informed consent form . 3 . Biopsy proven sarcoidosis . 4 . Documented hypercalciuria ( urinary excretion &gt; 4mg/kg calcium/day ) hypercalcemia within 4 week study entry . 5 . Historical evidence patient 's hypercalciuria/hypercalcemia relate sarcoidosis . This include serum parathyroid hormone ( PTH ) level elevate . 1 . A change antisarcoidosis medication within 3 month study entry . 2 . A history hyperparathyroidism another nonsarcoidosis cause hypercalcemia/hypercalciuria 3 . A history Cushing 's disease . 4 . Have diagnosis medical disorder sarcoidosis opinion investigator would complicate evaluation response treatment . 5 . Have use investigational drug within 1 month prior screen within 5 halflives investigational agent , whichever longer . 6 . Use loop thiazide diuretic hypertension disorder . 7 . Chronic use antacid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Sarcoidosis-Associated Calcium Dysregulation</keyword>
	<keyword>Sarcoidosis-Associated hypercalciuria</keyword>
	<keyword>hypercalcemia</keyword>
	<keyword>hypercalciuria</keyword>
	<keyword>nephrocalcinosis</keyword>
	<keyword>nephrolithiasis</keyword>
	<keyword>interstitial nephritis</keyword>
	<keyword>glomerulonephritis</keyword>
	<keyword>acute kidney disease</keyword>
	<keyword>chronic kidney disease</keyword>
</DOC>